[go: up one dir, main page]

HK1259001A1 - 癌症的预後和诊断方法 - Google Patents

癌症的预後和诊断方法

Info

Publication number
HK1259001A1
HK1259001A1 HK19101487.7A HK19101487A HK1259001A1 HK 1259001 A1 HK1259001 A1 HK 1259001A1 HK 19101487 A HK19101487 A HK 19101487A HK 1259001 A1 HK1259001 A1 HK 1259001A1
Authority
HK
Hong Kong
Prior art keywords
cancer
methods
patient
prognosis
diagnosis
Prior art date
Application number
HK19101487.7A
Other languages
English (en)
Inventor
Koshikawa Naohiko
Nakagawa Masatoshi
Yoshida Eisaku
Yoshimura Toru
Seiki Motoharu
Original Assignee
The University Of Tokyo
雅培日本有限公司
Abbott Japan Llc
國立大學法人東京大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50066470&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1259001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The University Of Tokyo, 雅培日本有限公司, Abbott Japan Llc, 國立大學法人東京大學 filed Critical The University Of Tokyo
Publication of HK1259001A1 publication Critical patent/HK1259001A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK19101487.7A 2012-08-13 2019-01-29 癌症的预後和诊断方法 HK1259001A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261682462P 2012-08-13 2012-08-13
US61/682462 2012-08-13
US13/962494 2013-08-08
US13/962,494 US20140045196A1 (en) 2012-08-13 2013-08-08 Methods of prognosis and diagnosis of cancer

Publications (1)

Publication Number Publication Date
HK1259001A1 true HK1259001A1 (zh) 2019-11-22

Family

ID=50066470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101487.7A HK1259001A1 (zh) 2012-08-13 2019-01-29 癌症的预後和诊断方法

Country Status (5)

Country Link
US (1) US20140045196A1 (zh)
JP (1) JP6328103B2 (zh)
CN (2) CN108469523A (zh)
HK (1) HK1259001A1 (zh)
WO (1) WO2014027701A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170089905A1 (en) * 2015-09-28 2017-03-30 Abbott Japan Co., Ltd. Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
RU2018127709A (ru) * 2016-01-22 2020-02-25 Отрэйсис, Инк. Системы и способы улучшения диагностики заболеваний
CN108780093A (zh) * 2016-03-09 2018-11-09 塞尚公司 作为膀胱癌标志物的嗜铬粒蛋白a
CN109486948A (zh) * 2018-10-16 2019-03-19 温州医科大学 一种功能驱动的个体化预测结直肠癌预后的多分子标志物及其装置与评价方法
EP3907504A4 (en) * 2019-01-04 2022-11-30 Kyoto University TEST METHOD FOR UC AND PRIMARY SCLEROSING CHOLANGITIS
US20230340580A1 (en) * 2020-02-25 2023-10-26 The University Of Tokyo LAMC2-NR6A1 Splicing Variant and Translation Product Thereof
CN113495159A (zh) * 2020-03-20 2021-10-12 郑州达诺生物技术有限公司 一种系统反应液、一种25羟基维生素d定量检测试剂盒及其使用方法
WO2023008329A1 (ja) * 2021-07-26 2023-02-02 国立大学法人東京大学 細胆管増生を伴う肝細胞を検出するためのバイオマーカー
EP4357782A1 (en) * 2022-10-18 2024-04-24 MU Bioteknik Aktiebolag Protein biomarker panel for the diagnosis of colorectal cancer
WO2024226899A1 (en) * 2023-04-28 2024-10-31 Abbott Laboratories Diagnosis of late-stage hepatocellular carcinoma

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955924B2 (en) * 1994-10-04 2005-10-18 Biostratum, Inc. Laminin chains: diagnostic uses
US5660982A (en) * 1994-10-04 1997-08-26 Tryggvason; Karl Laminin chains: diagnostic uses
DE19701607A1 (de) * 1997-01-17 1998-07-23 Hoechst Ag Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung
WO2001087239A2 (en) * 2000-05-12 2001-11-22 Fibrogen, Inc. Methods of affecting laminin 5 processing
FR2826292B1 (fr) * 2001-06-22 2004-01-23 Rhodia Chimie Sa Emulsions huile dans huile comprenant une silicone, dispersions de telles emulsions et utilisation
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
JPWO2003016907A1 (ja) * 2001-08-17 2004-12-02 エーザイ株式会社 生体試料中のラミニン５抗原の測定試薬及び測定方法
WO2004039401A2 (en) * 2002-10-29 2004-05-13 Sirpa Salo Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
WO2005083440A2 (en) * 2004-02-19 2005-09-09 Yale University Identification of cancer protein biomarkers using proteomic techniques
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
HUE028487T2 (en) * 2007-02-27 2016-12-28 Sentoclone Int Ab Detection of tumor cell multiplex using panel of agents associated with extracellular markers
JP5754844B2 (ja) * 2010-03-09 2015-07-29 国立大学法人 東京大学 泌尿器科がんの検査方法及び検査用キット
WO2012103424A2 (en) * 2011-01-27 2012-08-02 Virginia Commonwealth University Diagnostic and prognostic markers for metastasis
CN102621307B (zh) * 2012-03-12 2014-04-30 沈周俊 尿层粘连蛋白在制备诊断膀胱癌的医疗器械中的应用

Also Published As

Publication number Publication date
CN104755935B (zh) 2018-03-20
JP2015527562A (ja) 2015-09-17
WO2014027701A1 (en) 2014-02-20
CN108469523A (zh) 2018-08-31
JP6328103B2 (ja) 2018-05-23
CN104755935A (zh) 2015-07-01
HK1211345A1 (zh) 2016-05-20
US20140045196A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
HK1259001A1 (zh) 癌症的预後和诊断方法
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
TR201904386T4 (tr) Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
EA201590027A1 (ru) Способы детекции заболеваний или состояний
WO2014201516A3 (en) Biomarker identification
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2014028884A3 (en) Cancer diagnostics using biomarkers
MX356986B (es) Metodo para detectar aductos de nucleosomas.
IN2014CN01787A (zh)
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
MX373248B (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
IN2013CN01129A (zh)
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
EP3135774A3 (en) Complex sets of mirnas as non-invasive biomarkers for kidney cancer
MX359328B (es) Metodo para el diagnostico de enfermedad de niemann-pick.
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
BR112015014232A2 (pt) lesão renal aguda
WO2012139052A3 (en) Antibody biomarkers for diabetes
WO2014161910A3 (en) Methods and arrays for use in biomarker detection for prostate cancer
EP2415877A3 (en) Means and methods for diagnosing pancreatic cancer
WO2018187385A8 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING PANCREATIC CANCER